Last reviewed · How we verify

Moderil — Competitive Intelligence Brief

Moderil (RESCINNAMINE) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: rescinnamine. Area: Neuroscience.

marketed rescinnamine Synaptic vesicular amine transporter Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Moderil (RESCINNAMINE) — Pfizer.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Moderil TARGET RESCINNAMINE Pfizer marketed rescinnamine Synaptic vesicular amine transporter 1956-01-01
Austedo DEUTETRABENAZINE Teva marketed Synaptic vesicular amine transporter 2017-01-01
Xenazine TETRABENAZINE Bausch Health marketed Vesicular Monoamine Transporter 2 Inhibitor [EPC] Synaptic vesicular amine transporter 2008-01-01
Raunormin DESERPIDINE marketed Catecholamine-depleting Sympatholytic Synaptic vesicular amine transporter 1957-01-01
Vyvanse Vyvanse Vanderbilt University marketed Sodium-dependent dopamine transporter, Sodium-dependent noradrenaline transporter, Synaptic vesicular amine transporter
Ingrezza valbenazine Neurocrine marketed Potassium voltage-gated channel subfamily H member 2, Synaptic vesicular amine transporter, Synaptic vesicular amine transporter

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (rescinnamine class)

  1. Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Moderil — Competitive Intelligence Brief. https://druglandscape.com/ci/rescinnamine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: